Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

National Medical Care

This article was originally published in The Gray Sheet

Executive Summary

FDA lifts ban on import of hemodialysis bloodlines manufactured at the W. R. Grace subsidiary's Reynosa, Mexico facility. The ban was rescinded following FDA reinspection of the site "and a commitment by NMC to finish certain studies by May 1994 and, in the interim, to perform additional product final product testing" on an expanded sample base. The firm expects by April 14 to certify its Dublin, Ireland dialyzer facility, also on import alert, clearing the way for reinspection. The NMC facilities were placed on import alert in the summer of 1993 and were cited in a recent consent decree with FDA ("The Gray Sheet" Jan. 24, p. 6)
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT002078

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel